Microplastics, Fertility, and the Science Behind Headlines

Microplastics and Fertility

Are microplastics harming fertility? Researchers increasingly hear this question from concerned parents, couples trying to conceive, and readers responding to news coverage about plastics in food, water, and the environment.

Microplastics are widely detected across environmental systems and in some biological samples, but there is not yet conclusive evidence linking exposure to reproductive health outcomes. Understanding potential risks will require rigorous research, standardized measurement methods, and long-term studies.

Detecting Microplastics

Detecting microplastic particles, or evidence of exposure, does not by itself indicate adverse health outcomes. Determining whether their presence has meaningful implications for human health will require a more rigorous and consistent body of evidence.

Measurement itself is a significant challenge. Detecting microplastics in biological tissues is technically difficult, and scientific methods are still evolving. The particles vary widely in size, shape, polymer type, and chemical composition. Some are small enough to approach the nanoscale, where reliable detection, identification, and quantification remain technically challenging.

Analytical and Methodological Challenges

Experts from a National Academies of Sciences webinar series on microplastics and human health emphasize that microplastics should not be treated as a single, uniform hazard. Potential risks depend not only on the particle — its size, shape, and polymer type — but also on associated chemicals such as additives, degradation byproducts, and other co-exposures. These factors contribute to the current evidence base being difficult to interpret.

Analytical challenges are compounded by the absence of standardized methods. No universally standardized method exists for sampling, detecting, characterizing, quantifying, or reporting micro- or nanoplastics in environmental or biological samples. This complicates comparisons across studies and can undermine confidence in the reliability and reproducibility of reported findings.

For example, pyrolysis-gas chromatography-mass spectrometry (Py-GC-MS), a commonly used technique, detects chemical signatures associated with plastic polymers. Some of these compounds can also originate from natural biological materials. Without careful controls and validation, this overlap can lead to false positives.

Microplastics in Human Tissues

Several high-profile studies suggesting the presence of microplastics in human tissues — such as placentas, brains, or testes — have been questioned by other researchers due to the studies’ small sample sizes, limited contamination controls, and uncertainties in analytical methods.

For example, in response to a widely publicized study on plastics in the brain, scientists wrote to the publishing journal, highlighting “methodological challenges, such as limited contamination controls and lack of validation steps.” A separate study reporting large quantities of microplastics in dog and human testes drew similar scrutiny, with another group of researchers noting that “the analytical approach used is not robust enough to support these claims.”

These disputes reflect a broader scientific reality: Detecting microscopic plastic particles in biological tissues requires sensitive, well-validated analytical techniques, strict contamination controls, and —including standardized protocols, blanks, and plastic‑free materials—but also careful interpretation to avoid misclassification. Even well-intentioned studies can produce misleading results if these standards are not met. In turn, this can lead to false positives, inconsistent measurements, and overconfident claims about particle burdens.

Scientific Consensus and Research Gaps

Recognizing these challenges, researchers across disciplines are working toward a coordinated research agenda. Scientific forums and state-led national coalitions, including efforts associated with the National Academies of Sciences, have identified key gaps that should be addressed before reliable conclusions about health risks can be drawn.

Key Research Priorities

1. Methodological standardization: Harmonized protocols for sampling, detection, and analysis across environmental and biological samples would help make results more comparable and reproducible across laboratories.
2. Analytical detection: Detecting particles smaller than 10 microns, particularly nanoplastics, remains challenging. Improvements to methods such as Raman spectroscopy, Fourier-transform infrared spectroscopy (FTIR), and pyrolysis-based approaches could enhance reliability in complex samples.
3. Real-world exposure: Estimates of human exposure vary widely because data on inhalation, ingestion, and dermal pathways are still limited. More refined exposure models could account for particle types, environmental conditions, and different population groups.
4. Epidemiological evidence: Large-scale cohort studies, longitudinal data, and standardized exposure measurements are largely absent, limiting understanding of links between microplastic exposure and health outcomes.
5. Environmentally realistic conditions: Many laboratory toxicology studies rely on pristine plastic spheres at concentrations far higher than found in the real world. Studying more realistic particles and exposure scenarios would better inform potential health risks.

These priorities underscore a key point: The scientific community sees the value of further investigation, while also recognizing that the current evidence base remains incomplete.

Putting Risk in Context

Investigating the potential health impacts of plastics remains an important area of research, but emerging risks should be considered alongside established scientific evidence. Treating preliminary or uncertain risks as equivalent to well-established ones can distort research priorities, policy responses, and the allocation of resources.

Concerns about microplastics appear in everyday conversations. Parents may worry about microwaving baby bottles, storing breast milk or formula in plastic containers, using disposable diapers, or relying on plastic food storage. At the same time, plastics provide essential benefits, particularly in medicine, where they enable sterile packaging, affordable medical devices, and lifesaving hospital technologies.

Framing plastics solely as a threat overlooks these benefits, and risks oversimplifying a complex scientific question, highlighting the need to weigh both potential harms and established advantages when evaluating their role in daily life and public health.

Science and Public Perception

Public discussion does not always reflect the nuance of the underlying science. For example, a recent Netflix documentary linking plastics to infertility illustrates how preliminary findings can be interpreted as established conclusions before the scientific community reaches consensus.

Documentaries and media coverage are not scientific studies and are not subject to peer review, methodological transparency, or reproducibility standards. While they can raise awareness of emerging issues, they do not provide the evidence needed to establish causal relationships in human health.

Scientific progress typically emerges gradually, through incremental improvements in measurement, replication across studies, and long-term research. In the case of microplastics, that process is still underway, and careful investigation continues to build the evidence base.

Next Steps for Study

Uncertainties surrounding microplastics do not diminish the importance of understanding their potential health impacts. They underscore the need for continued research, improved analytical and methodological standards, and prudent efforts to limit unnecessary exposures while the evidence base develops.

Researchers across disciplines — including environmental science, toxicology, chemistry, and epidemiology — are working to better understand how these materials interact with biological and environmental systems. Advancing this work involves standardized analytical techniques, realistic exposure models, interdisciplinary collaboration, and long-term human studies.

For example, the National Academies of Sciences and other agencies have outlined steps to move microplastics research forward, including developing certified reference materials, improving contamination controls, building shared data infrastructures, and launching large-scale epidemiological studies. As these efforts progress, the evidence base will become clearer.

Until then, drawing sweeping conclusions from preliminary findings can risk misinforming the public and undermining scientific credibility. Investigating the potential relationship between microplastics and fertility remains important, but the current evidence does not justify heightened alarm. A careful, evidence-based approach  — focused on measurement, exposure assessment, and ongoing research — remains the most responsible path forward.

This publication was produced by Rice University’s Baker Institute for Public Policy. Wherever feasible, the material was reviewed by outside experts prior to release. Any errors or omissions are solely the responsibility of the author(s).

This material may be quoted or reproduced without prior permission, provided appropriate credit is given to the author(s) and Rice University’s Baker Institute for Public Policy. The views expressed herein are those of the individual author(s) and do not necessarily represent the views of Rice University’s Baker Institute for Public Policy.